
zzso a zzso human zzso zzso zzso induced clinically meaningful weight loss in a phase 2 study in obese individuals without zzso The present zzso phase 3 trial assessed the efficacy of zzso in maintaining weight loss achieved with a low-calorie diet zzso 

zzso participants zzso years, body mass index zzso or zzso with zzso who lost zzso of initial weight during a LCD zzso were randomly assigned to zzso zzso zzso per day or zzso zzso zzso for 56 zzso Diet and exercise counseling were provided throughout the zzso zzso end points were percentage weight change from zzso the proportion of participants that maintained the initial zzso weight loss, and the proportion that lost zzso of zzso weight zzso zzso zzso zzso zzso 

Participants zzso lost a mean zzso zzso zzso of screening weight during zzso From zzso to week 56, weight decreased an additional mean zzso zzso zzso with zzso and zzso zzso zzso with zzso zzso difference zzso zzso class intervals zzso to zzso zzso More participants receiving zzso zzso maintained the zzso zzso weight loss, compared with those receiving zzso zzso zzso odds ratio zzso zzso zzso zzso and zzso versus zzso of participants lost zzso of zzso weight zzso odds ratio zzso zzso zzso zzso zzso produced small but statistically significant improvements in several zzso risk factors compared with zzso zzso zzso disorders were reported more frequently with zzso than zzso but most events were zzso and mild or moderate in zzso 

zzso with diet and exercise, maintained weight loss achieved by caloric restriction and induced further weight loss over 56 zzso zzso in some cardiovascular zzso factors were also zzso zzso prescribed as zzso zzso per day, holds promise for improving the maintenance of lost zzso 

